Continuous Wireless Monitoring of Vital Signs & Automated Alerts in

Status Active, not recruiting

Clinical Trial Summary

The primary aim of this study is to test and assess the implementation and effectiveness of continuous wireless vital signs monitoring with real-time alerts on: The frequency of patients monitored with adequate data quality as adequate clinical user satisfaction in the initial versus the last part of the trial (primary outcome).

Clinical Trial Description

Over the last years, the applicants and research team partners have developed the WARD (Wireless Assessment of Respiratory and circulatory Distress) project, using continuous wireless monitoring of vital signs and artificial intelligence algorithms for data interpretation in high-risk patient admitted to medical and surgical wards. The WARD project combines continuous measurements of 10 different physiological modalities with machine learning to develop the WARD-Clinical Support System (WARD-CSS), based on multiple intelligent algorithms, that automatically monitors, interprets, predicts and alert clinical staff. Through a mobile device with a purpose-built Graphic User Interface (GUI), the WARD-CSS stimulates human-machine interaction to improve the monitoring of high-risk hospitalized patients. The WARD project has hitherto proven an unmet need for continuous monitoring and the potential for automatic detection and prediction of physiological deterioration events. Specifically, observational pilot studies of both patients with acute exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) and postoperative abdominal cancer surgery patients have shown that episodes of desaturation, tachycardia, tachypnea, and bradypnea are much more frequently detected using continuous vital signs monitoring than with existing Early Warning Score (EWS) systems. Ongoing investigations will determine the efficacy in two very selected populations of high-risk surgical patients and acutely ill medical patients with severe disease. This study will investigate the WARD-systems' implementation, and effectiveness of use and impact in a cohort of patientparticipants admitted ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05378139
Study type	Observational
Source	University Hospital Bispebjerg and Frederiksberg
Contact
Status	Active, not recruiting
Phase
Start date	February 1, 2021
Completion date	December 22, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05490303` - HeartGuide: Preliminary Study	N/A
Completed	`NCT05070819` - Atrial Natriuretic Peptide in Assessing Fluid Status	N/A
Not yet recruiting	`NCT04511403` - Prevalence of Oral Mucosal Alterations In a Sample of Egyptian Patients With Cardiovascular Diseases: A Hospital- Based Cross-Sectional Study
Not yet recruiting	`NCT04538469` - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Completed	`NCT02697760` - The CZT Dynamic Myocardial Perfusion Imaging
Terminated	`NCT05157568` - Pilot Randomized Clinical Trial of Live-streamed Cardiovascular Rehabilitation	N/A
Not yet recruiting	`NCT04160845` - Non-invasive Forehead Skin Temperature in Cardiac Surgery
Completed	`NCT04500912` - Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population	N/A
Not yet recruiting	`NCT06438159` - Impact of Mindfulness-Based Stress Reduction Meditation Practice on Patients After Cardiac Rehabilitation.	N/A
Recruiting	`NCT06154473` - Assessment of Patients Undergoing Cardiac Surgery and Admitted to the Intensive Care Unit
Not yet recruiting	`NCT05877755` - Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging	N/A
Completed	`NCT03394859` - Electronic Medical Records and Genomics (eMERGE) Phase III
Recruiting	`NCT05055830` - Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
Recruiting	`NCT04374799` - Heparin vs Placebo for Cardiac Catheterization	Phase 3
Completed	`NCT03174106` - Longterm Follow-up of Cardiac Patients With an Smartphone-Application	N/A
Recruiting	`NCT05531253` - Respired Gases in Patients Post Cardiac Surgery
Recruiting	`NCT04609228` - Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors
Recruiting	`NCT06149143` - Cardiac Performance System Data Collection Study - Minnesota
Recruiting	`NCT05725655` - Hot Water Immersion After Myocardial Infarction	N/A
Recruiting	`NCT06073509` - Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Hospitalized Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms